Back |
home / stock / evax / evax message board
Subject | By | Source | When |
---|---|---|---|
Evaxion Biotech Announces Successful Production of Personalized Cancer | subslover | investorshub | 05/10/2022 12:19:29 PM |
Some say this is the #1 biotech to | Dapper10 | investorshub | 12/31/2021 5:19:47 PM |
Not meIm a dealy. Plaza er | lakoob2 | investorshub | 11/04/2021 3:58:55 PM |
its amazin how this chit works, the machanics | TheFinalCD | investorshub | 11/04/2021 3:49:03 PM |
Thanks. Looks like a StockTwits pump! | Stock_Barber | investorshub | 11/04/2021 3:45:03 PM |
https://ih.advfn.com/stock-market/NASDAQ/evaxion-biotech-as-$EVAX/stock-news/8646 | TheFinalCD | investorshub | 11/04/2021 3:41:23 PM |
Thanks! Do you have a link to that news? | Stock_Barber | investorshub | 11/04/2021 3:25:30 PM |
Where we Go? | ollik78 | investorshub | 11/04/2021 3:22:35 PM |
going to do a clinical trial with $MRK's | formerdtrader | investorshub | 11/04/2021 3:21:36 PM |
No public news to explain it... | Stock_Barber | investorshub | 11/04/2021 3:20:12 PM |
what in tarnation is going on over here | TheFinalCD | investorshub | 11/04/2021 3:17:19 PM |
Hope yall bought that $15 dip for the rip!$ | Jess070283 | investorshub | 11/04/2021 2:09:41 PM |
In premarket it's currently 15.8. Where do you | duderaja | investorshub | 11/04/2021 10:32:32 AM |
23.31 in AH. Closed regular session @ 6.50 | crudeoil24 | investorshub | 11/03/2021 9:14:51 PM |
We are offering 2,597,402 ADSs, with each ADS | crudeoil24 | investorshub | 11/03/2021 8:30:11 PM |
News, Short Squeeze, Breakout and More Instantly...
Central AI-Immunology™ Building Block: Evaxion’s proprietary in-house developed building block, EvaxMHC, is used across the AI-Immunology™ platform Improved Performance: Utilizing a state-of-the-art novel deep-learning framework as well as training on public and...
COPENHAGEN, Denmark, July 03, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today issued the following letter to shareholders...
Positive Feedback Received: An International Preliminary Report on Patentability (IPRP) indicates promising prospects for obtaining granted patents and protecting the invention Unique Attributes and Inventiveness: The feedback highlights the distinct and inventive nature of all rele...